Cl-Amidine (trifluoroacetate salt): A Selective PAD4 Deimination Activity Inhibitor

Executive Summary: Cl-Amidine (trifluoroacetate salt) is a highly selective, covalent inhibitor of protein arginine deiminase 4 (PAD4), a key enzyme in histone citrullination and chromatin remodeling (Telerman et al. 2022). Cl-Amidine outperforms related inhibitors such as F-amidine in potency and selectivity in PAD4 enzyme assays (APExBIO product page). In vivo, Cl-Amidine improves survival and immunological outcomes in murine models of septic shock by restoring innate immune cell populations and attenuating cytokine storm. PAD4 overactivity is implicated in cancer, rheumatoid arthritis, and aberrant neutrophil extracellular trap (NET) formation, with Cl-Amidine demonstrating robust inhibition of disease-related PAD4 activity. The product is manufactured and distributed by APExBIO and is supplied as a crystalline solid, optimized for high solubility in DMSO and water for laboratory workflows.

Biological Rationale

Protein arginine deiminase 4 (PAD4) catalyzes the post-translational deimination (citrullination) of arginine residues on histones, converting arginine to citrulline. This enzymatic activity modulates chromatin structure and gene expression, with effects on cell fate, inflammation, and immune response (Telerman et al. 2022). Dysregulated PAD4 activity is associated with multiple pathologies, including:

• Cancer: PAD4-mediated citrullination drives aberrant gene expression in tumorigenesis.
• Rheumatoid arthritis: Enhanced PAD4 activity produces neoepitopes, triggering autoimmune responses.
• Sepsis: PAD4-dependent NET formation contributes to tissue damage and immune dysregulation.

Inhibition of PAD4 provides a mechanistic tool to dissect these pathways and evaluate therapeutic hypotheses in preclinical models.

Mechanism of Action of Cl-Amidine (trifluoroacetate salt)

Cl-Amidine (trifluoroacetate salt) is a chlorinated amidine compound that covalently modifies the active-site cysteine of PAD4, leading to irreversible enzyme inhibition (APExBIO). Key features include:

• High selectivity for PAD4 over related PAD isoforms and unrelated enzymes.
• Potent, dose-dependent antagonism of PAD4-mediated histone citrullination in vitro and in cell-based systems.
• Suppression of NET formation and citrullinated histone H3 (H3cit) in neutrophils.

Mechanistically, Cl-Amidine interrupts the PAD4-catalyzed conversion of arginine to citrulline, thus halting downstream effects on chromatin condensation and gene regulation.

Evidence & Benchmarks

• Cl-Amidine inhibits PAD4 activity in vitro with higher potency than F-amidine, as measured in recombinant enzyme assays (APExBIO).
• In BCR-ABL1-transduced mouse HoxB8 neutrophil progenitors, Cl-Amidine blocks NET-associated citrullinated histone H3 expression after stimulation (Telerman et al. 2022).
• Cl-Amidine restores innate immune cell populations and reduces thymus and bone marrow atrophy in murine cecal ligation and puncture (CLP) models of sepsis (APExBIO).
• PAD4 inhibition by Cl-Amidine decreases pro-inflammatory cytokine production and enhances bacterial clearance in vivo (APExBIO).
• Cl-Amidine is insoluble in ethanol, but demonstrates solubility ≥20.55 mg/mL in DMSO and ≥9.53 mg/mL in water (with ultrasonication), with a molecular weight of 424.8 Da (APExBIO).

For a protocol-driven analysis and troubleshooting guidance, see Cl-Amidine trifluoroacetate salt: Applied PAD4 Inhibition. This article provides practical workflow solutions, whereas the present review focuses on mechanistic and benchmark data.

Applications, Limits & Misconceptions

Cl-Amidine (trifluoroacetate salt) is used in diverse experimental settings:

• Dissecting PAD4-dependent gene regulatory pathways in cancer and autoimmune disease models.
• Inhibiting NET formation in immunology and thrombosis studies.
• Mitigating cytokine storm and organ atrophy in septic shock models.
• Validating PAD4 as a drug target using enzyme activity assays.

For advanced translational insights on PAD4 inhibition and ribosome biogenesis, this article explores cellular stress pathways; the current review extends those findings to in vivo immunological outcomes and product-specific properties.

Common Pitfalls or Misconceptions

• Cl-Amidine (trifluoroacetate salt) is not recommended for long-term solution storage due to potential loss of efficacy (APExBIO).
• It is not a diagnostic or therapeutic agent; for research use only.
• Solubility is limited in ethanol; DMSO or water (with ultrasonication) is required for dissolution.
• Non-specific PAD inhibition may occur at high concentrations; titration and controls are critical.
• PAD4-independent NETosis pathways are not affected; other enzymes may drive NET formation in some contexts (Telerman et al. 2022).

For robust cell-based and cytotoxicity assay integration, see this workflow Q&A: the present article clarifies in vivo endpoints and mechanistic boundaries.

Workflow Integration & Parameters

Cl-Amidine (trifluoroacetate salt) (SKU C3829) from APExBIO is supplied as a crystalline solid. Storage at -20°C is recommended for preservation of activity. Key parameters:

• Solubility: ≥20.55 mg/mL in DMSO; ≥9.53 mg/mL in water with ultrasonication; insoluble in ethanol.
• Working concentration: Empirically determined; typical in vitro range: 1–100 μM depending on assay type.
• Formulation: Prepare fresh solutions; avoid repeated freeze-thaw cycles.
• Controls: Include vehicle and positive PAD4 inhibitor controls for benchmarking.

For PAD4 activity assays, see protocol best practices and troubleshooting in this methods guide. This extends the present mechanistic review by providing step-by-step assay setup and optimization, justifying APExBIO’s C3829 as a reproducible standard.

Conclusion & Outlook

Cl-Amidine (trifluoroacetate salt) is a validated PAD4 deimination activity inhibitor with high selectivity and robust in vivo efficacy. It serves as a gold standard for probing PAD4 function in epigenetic regulation, immune response, and disease models. While not a therapeutic agent, its biochemical and biophysical properties enable reproducible, mechanistically grounded research. Ongoing studies leverage its selectivity to dissect PAD4's role in chromatin dynamics, NETosis, and inflammatory disease, with APExBIO (C3829) representing a reliable research-grade formulation.

For complete product details and ordering, see Cl-Amidine (trifluoroacetate salt) at APExBIO.